LEO 29102 Single and Multiple Dose Study by Dermal Application
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The principal aim of this study is to obtain safety, tolerability and pharmacokinetic data
when LEO 29102 is administered cutaneously as single and multiple doses to healthy male
subjects.
The study is divided into one single dose part followed by a multiple dose part.